• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类静脉内支架狭窄和支架闭塞的病理特征。

Pathologic characteristics of human venous in-stent stenosis and stent occlusion.

机构信息

Section of Interventional Radiology, Department of Radiology, University of Michigan Medical School, Ann Arbor, MI.

Brown University Medical School, Providence, RI.

出版信息

J Vasc Surg Venous Lymphat Disord. 2023 Jan;11(1):109-118.e2. doi: 10.1016/j.jvsv.2022.07.002. Epub 2022 Aug 9.

DOI:10.1016/j.jvsv.2022.07.002
PMID:35961633
Abstract

OBJECTIVE

The objective of this study was to determine the pathologic features of venous in-stent stenosis over time occurring in bare metal stents.

METHODS

Endovascular biopsy samples were obtained prospectively from venous bare metal stents implanted in 2009 through 2018. All samples were formalin-fixed, paraffin-embedded and stained with hematoxylin and eosin. Samples were examined by a cardiovascular pathologist to estimate the amount of its constituent components, which included fresh thrombus, organizing thrombus, old thrombus, or diffuse intimal thickening (DIT), and pathologic features including calcification, neovascularization, and hemosiderin deposition. This pathologic characterization was correlated with time following stent implantation to discern time-dependence of pathologic evolution of in-stent stenosis using both descriptive statistics and binary logistic regression.

RESULTS

A total of 254 post-stent venograms with biopsies of in-stent contents from 148 unique patients were studied. Fresh thrombus and organizing thrombus were both present across all studied time intervals. Old thrombus was seen beginning at approximately 2 weeks and DIT at approximately 4 weeks. Calcification was a rare finding encountered at later time intervals. The prevalence of each component varied with time: the probability of encountering fresh thrombus (P = .010) and organizing thrombus (P = .008) decreased over time. By contrast, the probability of finding DIT (P = .002) and calcifications (P < .001) increased over time. The presence of old thrombus, neovascularization, or hemosiderin did not demonstrate time dependence. Diffuse intimal thickening was frequently seen along with organizing thrombus as well as independently, and in many instances, these two features were directly merged.

CONCLUSIONS

The evolution of human venous in-stent restenosis appears to follow a time-dependent course, suggesting a possible progressive evolution from fresh and organizing thrombus to DIT. Contrasted with the literature on arterial in-stent restenosis, vein in-stent restenosis may have an increased thrombus prevalence (both organizing and old thrombus). DIT is a primary feature of late in-stent stenosis and may explain in part why many of these lesions may not respond to thrombolytic or anticoagulant treatment alone.

摘要

目的

本研究旨在确定裸金属支架内静脉再狭窄的病理特征随时间的变化。

方法

前瞻性地从 2009 年至 2018 年植入的静脉裸金属支架中获取血管内活检样本。所有样本均经福尔马林固定、石蜡包埋,并进行苏木精和伊红染色。由心血管病理学家检查样本,以评估其组成成分的数量,包括新鲜血栓、机化血栓、陈旧血栓或弥漫性内膜增厚(DIT),以及包括钙化、新生血管形成和含铁血黄素沉积在内的病理特征。将这种病理特征与支架植入后的时间相关联,以通过描述性统计和二项逻辑回归来辨别支架内狭窄的病理演变随时间的依赖性。

结果

共研究了 148 例患者的 254 个支架后静脉造影和支架内内容物活检。所有研究时间间隔均存在新鲜血栓和机化血栓。陈旧血栓在大约 2 周时出现,DIT 在大约 4 周时出现。钙化是一种罕见的发现,出现在较晚的时间间隔。每个成分的患病率随时间变化:发现新鲜血栓(P=.010)和机化血栓(P=.008)的概率随时间降低。相比之下,发现 DIT(P=.002)和钙化(P <.001)的概率随时间增加。陈旧血栓、新生血管形成或含铁血黄素的存在不具有时间依赖性。弥漫性内膜增厚常与机化血栓一起出现,也可独立出现,在许多情况下,这两种特征直接合并。

结论

人类静脉内支架再狭窄的演变似乎遵循时间依赖性过程,提示从新鲜和机化血栓到 DIT 可能存在逐渐演变。与动脉内支架再狭窄的文献相比,静脉内支架再狭窄可能具有更高的血栓发生率(包括机化和陈旧血栓)。DIT 是晚期支架内狭窄的主要特征,部分解释了为什么许多此类病变可能无法单独对溶栓或抗凝治疗产生反应。

相似文献

1
Pathologic characteristics of human venous in-stent stenosis and stent occlusion.人类静脉内支架狭窄和支架闭塞的病理特征。
J Vasc Surg Venous Lymphat Disord. 2023 Jan;11(1):109-118.e2. doi: 10.1016/j.jvsv.2022.07.002. Epub 2022 Aug 9.
2
Histological Features of In-Stent Restenosis after Iliac Vein Thrombus Removal and Stent Placement in a Goat Model.支架内再狭窄的组织学特征:在山羊模型中髂静脉血栓清除和支架置入后的研究。
J Vasc Interv Radiol. 2024 Apr;35(4):611-617. doi: 10.1016/j.jvir.2023.12.567. Epub 2024 Jan 1.
3
Etiology of iliocaval stent thrombosis.髂股静脉支架血栓形成的病因。
J Vasc Surg Venous Lymphat Disord. 2020 Mar;8(2):207-210. doi: 10.1016/j.jvsv.2019.09.017. Epub 2019 Dec 14.
4
An overview of in-stent restenosis in iliofemoral venous stents.髂股静脉支架内再狭窄的概述。
J Vasc Surg Venous Lymphat Disord. 2022 Mar;10(2):492-503.e2. doi: 10.1016/j.jvsv.2021.10.011. Epub 2021 Nov 11.
5
Stent Grafts Provided Superior Primary Patency for Central Venous Stenosis Treatment in Comparison with Angioplasty and Bare Metal Stent: A Retrospective Single Center Study on 70 Hemodialysis Patients.与血管成形术和裸金属支架相比,覆膜支架在治疗中心静脉狭窄方面具有更高的初始通畅率:一项针对70例血液透析患者的回顾性单中心研究。
Vasc Endovascular Surg. 2016 May;50(4):221-30. doi: 10.1177/1538574416639149. Epub 2016 Apr 19.
6
7
Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent.金精三羧酸和RG - 13577的矛盾效应:被动涂层支架中的急性血栓形成和支架内狭窄
J Endovasc Ther. 2006 Feb;13(1):94-103. doi: 10.1583/05-1641.1.
8
Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.带有CD146抗体和纳米结构的晚期内皮祖细胞捕获支架可减少支架内再狭窄和血栓形成。
Acta Biomater. 2020 Jul 15;111:91-101. doi: 10.1016/j.actbio.2020.05.011. Epub 2020 May 17.
9
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.OCT 评价药物涂层球囊与金属裸支架治疗初发冠状动脉病变的内膜增生(IN-PACT CORO):一项随机对照试验的研究方案。
Trials. 2012 May 6;13:55. doi: 10.1186/1745-6215-13-55.
10
Failure of drug-coated balloon angioplasty to treat bare metal in-stent restenosis accompanied by late stent thrombosis but successful treatment of binary in-stent restenosis.药物涂层球囊血管成形术治疗裸金属支架内再狭窄伴晚期支架血栓形成失败,但成功治疗了双支架内再狭窄。
J Cardiol Cases. 2019 May 16;20(3):84-87. doi: 10.1016/j.jccase.2019.04.007. eCollection 2019 Sep.

引用本文的文献

1
RevCore thrombectomy system for treatment of chronic left external and common iliac vein stent occlusion.用于治疗慢性左髂外静脉和髂总静脉支架闭塞的RevCore血栓切除术系统。
J Vasc Surg Cases Innov Tech. 2024 Mar 12;10(3):101482. doi: 10.1016/j.jvscit.2024.101482. eCollection 2024 Jun.
2
Endovascular mechanical thrombectomy of iliofemoral venous stent occlusion with the novel RevCore thrombectomy system: case reports and literature review.使用新型RevCore血栓切除术系统对髂股静脉支架闭塞进行血管内机械血栓切除术:病例报告及文献综述
J Vasc Surg Cases Innov Tech. 2024 Feb 14;10(3):101432. doi: 10.1016/j.jvscit.2024.101432. eCollection 2024 Jun.
3
Review of the literature supporting international clinical practice guidelines on iliac venous stenting and their applicability to Australia and New Zealand practice.
支持髂静脉支架置入术国际临床实践指南的文献回顾及其对澳大利亚和新西兰实践的适用性。
J Vasc Surg Venous Lymphat Disord. 2024 Sep;12(5):101843. doi: 10.1016/j.jvsv.2024.101843. Epub 2024 Feb 3.
4
Mechanical thrombectomy of venous in-stent thrombosis with the novel RevCore thrombectomy system: A report of 2 cases.使用新型RevCore血栓切除术系统对静脉支架内血栓进行机械性血栓切除术:2例报告
Radiol Case Rep. 2023 Nov 22;19(2):576-580. doi: 10.1016/j.radcr.2023.10.072. eCollection 2024 Feb.